Late last week, (PHE) reported that a UK man infected with the 鈥渨orld鈥檚 worst鈥 antibiotic resistant 鈥渟uper-gonorrhoea鈥 has been successfully treated. The case was initially announced by PHE in March, and widely publicized in the mainstream . The infection, contracted in southeast Asia, is resistant to both elements of the recommended dual first-line treatment, azithromycin and ceftriaxone. the patient received a course of (a broad-spectrum carbapenem antibiotic administered intravenously), which successfully cleared the infection. Two subsequent cases with similar resistance profiles have been reported in Australia.
The progressive development and spread of antibiotic resistant Neisseria gonorrhoeae, a sexually transmitted bacterial infection, has been an evolving public health concern . Seemingly inexorably, since the introduction of antibiotics, strains of N. gonorrhoeae have been found with resistance to sulfonamides, penicillins, fluoroquinolones, tetracyclines, and azithromycin. Since around 2010, most evidence-based guidelines recommend dual therapy with a 3rd or 4th generation cephalosporin plus azithromycin or doxycycline, although subsequent spread of resistance means that even these relatively well-tolerated regimens are failing. The US CDC鈥檚 Gonococcal Isolate Surveillance Project (), now in its fourth decade, is an example of a long-running AMR 果冻传媒影音 effort. The WHO runs (the Gonococcal Antimicrobial Surveillance Programme), and N. gonorrhoeae is a in the WHO鈥檚 for new antibiotics, and in the WHO 果冻传媒影音 platform. UK health agencies track gonorrhoeae resistance, with a recent Lancet ID publication detailing of high-level azithromycin resistance in England, and another recent publication focusing on with multi-drug resistance gonorrhoeae in England and Wales.
Gonorrhoeae would seem to be an ideal candidate for multidisciplinary research on AMR. Understanding and addressing transmission networks and treatment seeking across different contexts requires expertise in social science and human sexual behaviour. Targeted testing strategies in London and South Africa, and a safer sex messaging intervention, are being evaluated by LSHTM researchers. should improve detection and timely treatment. are under investigation, including work by LSHTM researchers. A recent shows how elucidation of bacterial factors can inform novel interventions. How can these different strands of inquiry be pulled together for public health benefit?
LSHTM's short courses provide opportunities to study specialised topics across a broad range of public and global health fields. From AMR to vaccines, travel medicine to clinical trials, and modelling to malaria, refresh your skills and join one of our short courses today.